Acetylated Benzothiazolone As Homobivalent SPECT Metallo-Radiopharmaceutical Tc-(6-AcBTZ)DTPA: Design, Synthesis, and Preclinical Evaluation for Mapping 5-HT Receptors

Overview

Journal ACS Omega

Publisher American Chemical Society

Specialty Chemistry

Date 2019 Aug 29

PMID 31460097

Authors

Preeti Jha

Shubhra Chaturvedi

Anju

Ankur Kaul

Nidhi Jain

Anil K Mishra

Affiliations

Soon will be listed here.

Abstract

Mapping different structural forms of serotonin subtypes 5-HT-5-HT using a selective-specific ligand with good pharmacokinetics and brain permeability can open avenues for personalized medication in depressed population. Herein, the selective 5-HT antagonist, modified for enhanced brain permeation, is developed as a homobivalent ligand, (6-AcBTZ)DTPA. After in-depth computational studies to probe the binding mechanism, two-step synthesis lead to (6-AcBTZ)DTPA. Biocompatibility studies indicated cytocompatibility with 3.6-1.64% cell death (0.1 mM-1 pM) and hemocompatibility with 2.33% hemolysis of human erythrocytes. When Tc-radiolabeled in a quantitative yield (98%), a stable preparation was obtained with 7.4 and 3.5% dissociation upon incubation with human serum and excess cysteine. The single-photon-emission computed tomography (SPECT) tracer Tc-(6-AcBTZ)DTPA showed biphasic clearance ( = 0.5 min and = 482 min) and maximum brain uptake of 0.42 ± 0.02% ID/g with the regional localization (hippocampus: 11.38% ID/g; cortex: 26.42% ID/g; cerebellum: 25.23% ID/g). Thus, the Tc-metal-based SPECT neurotracer holds potential for neuroreceptor mapping.

References

Plenevaux A, Weissmann D, Aerts J, Lemaire C, Brihaye C, Degueldre C . Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in.... J Neurochem. 2000; 75(2):803-11. DOI: 10.1046/j.1471-4159.2000.0750803.x. View

Heimbold I, Drews A, Syhre R, Kretzschmar M, Pietzsch H, Johannsen B . A novel technetium-99m radioligand for the 5-HT(1A) receptor derived from desmethyl-WAY-100635 (DWAY). Eur J Nucl Med Mol Imaging. 2002; 29(1):82-7. DOI: 10.1007/s00259-001-0660-x. View

Mouithys-Mickalad A, Poupaert J, Spampinato S, Lesieur D . Synthesis and pharmacological evaluation of 6-piperidino- and 6-piperazinoalkyl-2(3H)-benzothiazolones as mixed sigma/5-HT(1A) ligands. Bioorg Med Chem Lett. 2002; 12(8):1149-52. DOI: 10.1016/s0960-894x(02)00123-3. View

Geurts F, De Schutter E, Timmermans J . Localization of 5-HT2A, 5-HT3, 5-HT5A and 5-HT7 receptor-like immunoreactivity in the rat cerebellum. J Chem Neuroanat. 2002; 24(1):65-74. DOI: 10.1016/s0891-0618(02)00020-0. View

Martin-Cora F, Pazos A . Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species. Br J Pharmacol. 2003; 141(1):92-104. PMC: 1574165. DOI: 10.1038/sj.bjp.0705576. View

Laruelle M, Slifstein M, Huang Y . Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography. Mol Imaging Biol. 2003; 5(6):363-75. DOI: 10.1016/j.mibio.2003.09.009. View

Kanner A . Is major depression a neurologic disorder with psychiatric symptoms?. Epilepsy Behav. 2004; 5(5):636-44. DOI: 10.1016/j.yebeh.2004.07.008. View

Xie Z, Bhushan R, Daniels D, Portoghese P . Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells. Mol Pharmacol. 2005; 68(4):1079-86. DOI: 10.1124/mol.105.012070. View

Soulier J, Russo O, Giner M, Rivail L, Berthouze M, Ongeri S . Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies. J Med Chem. 2005; 48(20):6220-8. DOI: 10.1021/jm050234z. View

10.

Defraiteur C, Lemaire C, Luxen A, Plenevaux A . Radiochemical synthesis and tissue distribution of p-[18F]DMPPF, a new 5-HT1A ligand for PET, in rats. Nucl Med Biol. 2006; 33(5):667-75. DOI: 10.1016/j.nucmedbio.2006.03.010. View

11.

Hirvonen J, Karlsson H, Kajander J, Lepola A, Markkula J, Rasi-Hakala H . Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol. 2007; 11(4):465-76. DOI: 10.1017/S1461145707008140. View

12.

Siracusa M, Salerno L, Modica M, Pittala V, Romeo G, Amato M . Synthesis of new arylpiperazinylalkylthiobenzimidazole, benzothiazole, or benzoxazole derivatives as potent and selective 5-HT1A serotonin receptor ligands. J Med Chem. 2008; 51(15):4529-38. DOI: 10.1021/jm800176x. View

13.

Medina R, Sallander J, Benhamu B, Porras E, Campillo M, Pardo L . Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity. J Med Chem. 2009; 52(8):2384-92. DOI: 10.1021/jm8014553. View

14.

Savitz J, Lucki I, Drevets W . 5-HT(1A) receptor function in major depressive disorder. Prog Neurobiol. 2009; 88(1):17-31. PMC: 2736801. DOI: 10.1016/j.pneurobio.2009.01.009. View

15.

Hedlund P . The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl). 2009; 206(3):345-54. PMC: 2841472. DOI: 10.1007/s00213-009-1626-0. View

16.

Kane R . Thermodynamics of multivalent interactions: influence of the linker. Langmuir. 2010; 26(11):8636-40. PMC: 2877167. DOI: 10.1021/la9047193. View

17.

Leopoldo M, Lacivita E, Berardi F, Perrone R, Hedlund P . Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. Pharmacol Ther. 2010; 129(2):120-48. PMC: 3031120. DOI: 10.1016/j.pharmthera.2010.08.013. View

18.

Paila Y, Tiwari S, Sengupta D, Chattopadhyay A . Molecular modeling of the human serotonin(1A) receptor: role of membrane cholesterol in ligand binding of the receptor. Mol Biosyst. 2010; 7(1):224-34. DOI: 10.1039/c0mb00148a. View

19.

Tanaka T, Nomura W, Narumi T, Masuda A, Tamamura H . Bivalent ligands of CXCR4 with rigid linkers for elucidation of the dimerization state in cells. J Am Chem Soc. 2010; 132(45):15899-901. DOI: 10.1021/ja107447w. View

20.

Numata J, Juneja A, Diestler D, Knapp E . Influence of spacer-receptor interactions on the stability of bivalent ligand-receptor complexes. J Phys Chem B. 2012; 116(8):2595-604. DOI: 10.1021/jp211383s. View